Csenge Advisory Group
DGX icon

Csenge Advisory Group’s Quest Diagnostics DGX Stock Holding History

Csenge Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$204K Buy
+873
New +$202K 0.01% 719
2017
Q4 		– Sell
-6,561
Closed -$614K – 258
2017
Q3 		$614K Buy
+6,561
New +$697K 0.24% 100

Other funds holding DGX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Csenge Advisory Group's DGX Position: Q3 2026 in Review

Csenge Advisory Group opened a new position in Quest Diagnostics (DGX) in Q3 2026: 873 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #719 among its holdings. This is a return to the name: Csenge Advisory Group previously reported a position in DGX as recently as Q3 2017.

Csenge Advisory Group first reported a position in DGX in Q3 2017 and has held it in 2 quarters since. The position peaked at $614K in Q3 2017. 661 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Csenge Advisory Group held 873 shares of Quest Diagnostics worth $204K as of Q3 2026.
  • Quest Diagnostics was a new Csenge Advisory Group position in Q3 2026.
  • Quest Diagnostics made up 0.01% of Csenge Advisory Group's portfolio in Q3 2026, its #719 holding.
  • Csenge Advisory Group first reported a position in Quest Diagnostics in Q3 2017 and has held it in 2 quarters since.
  • Csenge Advisory Group's Quest Diagnostics position peaked at $614K in Q3 2017.
  • 661 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Csenge Advisory Group's 13F filing for Q3 2026, filed 4 Nov 2026.